April 4 (Reuters) - Medical device maker Boston Scientific said on Thursday the U.S. Federal Trade Commission has requested additional information from the company related to the review of its $3.7 billion deal to buy Axonics . (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.93 USD | +0.36% | +0.15% | +7.57% |
Apr. 04 | Boston Scientific, Axonics Receive FTC Second Request on Merger Deal | MT |
Apr. 04 | Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information | DJ |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
72.16 USD | -1.39% | +6.37% | 108B | ||
66.93 USD | +0.36% | +0.15% | 3.4B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.57% | 3.4B | |
+13.13% | 128B | |
-8.76% | 10.65B | |
+3.60% | 8.82B | |
+18.90% | 7.19B | |
+22.42% | 4.99B | |
-0.16% | 3.03B | |
-4.80% | 2.14B | |
-4.72% | 2B | |
-22.91% | 1.79B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal